Article
For John Bingner Lyman, MD, time spent in his wood shop is just plane fun.
Alkeus Pharmaceuticals receives FDA Rare Pediatric Disease and Fast Track designations for gildeuretinol as treatment for Stargardt disease
ROP: Treating and preventing blindness in preterm babies
Study explores the true costs of treating pediatric cataracts
Managing a changing landscape of IRD pediatric cases
Cerebral visual impairment: A growing concern in pediatric vision loss
Factors affecting ROP development in the 8 weeks following birth
